Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Novel, selective estrogen receptor beta agonists in early development at Lilly

Jan. 5, 2005

Synthesis and biological activity of YM-92088, a novel nonsteroidal androgen receptor antagonist

Jan. 4, 2005

NDA submission for premature ejaculation treatment dapoxetine hydrochloride

Dec. 30, 2004

FDA approves Enablex for overactive bladder

Dec. 27, 2004

Improved PDE5 inhibitors selected for clinical studies on erectile dysfunction

Dec. 16, 2004

Recordati to develop silodosin for BPH in Europe

Dec. 15, 2004

Novel PDE5 inhibitor from Fujisawa

Dec. 13, 2004

Researchers at Dynogen describe a new treatment for urinary tract disorders

Dec. 7, 2004

Conivaptan increases serum sodium levels in patients with hyponatremia

Dec. 3, 2004

Approvable letter for hyponatremia drug YM-087

Dec. 3, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...